Clinical trial
A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)
NCT01347710 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)
- Lead sponsor
- Lantheus Medical Imaging
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- September 30, 2013
- Enrollment
- 795 (actual)
- Sites
- 81
Conditions
As the registry lists them; a condition with its own page is linked.